AcelRX Pharmaceuticals Inc (ACRX)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 570k | 507k | 252k | 0 | 253k | 117k | 281k | 0 |
| Operating Income | -13.57M | -6.63M | -7.43M | -5.33M | -3.97M | -3.31M | -4.28M | -4.24M |
| Pre Tax Income | 70.67M | -6.74M | -7.49M | 64k | -4.43M | -1.42M | -4.51M | -3.95M |
| Net Income | 70.66M | -7.07M | -12.6M | -8.15M | -4.37M | -1.36M | -4.52M | -3.95M |
| Preferred Dividends | 0 | -315k | -5.11M | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | 69.81M | -89.55M | -7.43M | -5.33M | -3.97M | -3.31M | -4.28M | -2.99M |
| EBITDA | -8.21M | -6.21M | -7.04M | -5.07M | -3.92M | -3.31M | -4.28M | -4.24M |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 17.36M | 8M | 2.15M | 2.29M | 5.42M | 2.82M | 1.77M | 651k |
| Operating Income | -31.96M | -38.68M | -35.73M | -54.21M | -40.96M | -35.97M | -36.63M | -16.89M |
| Pre Tax Income | -43.19M | -52.21M | -47.15M | -53.24M | -40.38M | -35.09M | 47.77M | -10.29M |
| Net Income | -43.16M | -51.51M | -47.15M | -53.24M | -40.38M | -35.1M | 42.33M | -18.4M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | -5.43M | 0 |
| Basic Earnings Per Share (EPS) | -0.952 | -1.012 | -0.599 | -0.669 | -0.409 | -0.257 | 5.683 | -1.085 |
| EBIT | -31.96M | -38.68M | -35.73M | -52.87M | -37.65M | -35.97M | -35.5M | -16.89M |
| EBITDA | -29.91M | -36.94M | -35.23M | -52.54M | -39.86M | -34.87M | -30.04M | -16.58M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
